Presenter at GENAP Summit 2026 in Vienna

Marsha Steed will be presenting at the upcoming GENAP Summit 2026, taking place May 5–6, 2026, in Vienna, Austria.

GENAP 2026 returns as a premier international platform for advancing pharmaceutical manufacturing, aseptic processing, and Gene & Cell Therapy (GCT) innovation. As the industry accelerates toward increased automation, regulatory transformation, and breakthrough therapies, the summit brings together global experts to share practical insights, real-world case studies, and forward-thinking strategies shaping the future of aseptic and advanced therapy manufacturing.

As Founder & CEO of Steed MicroBio, Marsha contributes her expertise in microbiology, sterility assurance, and contamination control—areas that remain critical as technologies evolve and regulatory expectations intensify. Her participation reflects Steed MicroBio’s commitment to supporting compliant, resilient, and future-ready manufacturing systems in both traditional pharmaceutical and emerging GCT environments.

Presenting at GENAP 2026 underscores Marsha’s role as a trusted industry leader and highlights Steed MicroBio’s growing global presence in advancing microbiology excellence across…